<html>
  <div class="bg-white p-4 rounded-md shadow-md">
    <h2 class="text-lg font-bold mb-2">Safety Profile: A Breakthrough in Efficacy</h2>
    <p class="text-gray-600 mb-4">As a healthcare professional, you understand the importance of balancing efficacy with safety when treating patients with cancer. Oncozen has been designed to provide a superior safety profile while delivering a breakthrough in efficacy.</p>
    <ul class="list-none mb-4">
      <li class="flex items-start mb-2">
        <svg class="w-4 h-4 text-green-600 mr-2" fill="none" stroke="currentColor" viewBox="0 0 24 24" xmlns="http://www.w3.org/2000/svg"><path stroke-linecap="round" stroke-linejoin="round" stroke-width="2" d="M9 12l2 2 4-4m5-3l2 2 4-4M12 9v3"></path></svg>
        <span class="text-gray-600">Lower incidence of severe adverse events compared to existing treatments</span>
      </li>
      <li class="flex items-start mb-2">
        <svg class="w-4 h-4 text-green-600 mr-2" fill="none" stroke="currentColor" viewBox="0 0 24 24" xmlns="http://www.w3.org/2000/svg"><path stroke-linecap="round" stroke-linejoin="round" stroke-width="2" d="M9 12l2 2 4-4m5-3l2 2 4-4M12 9v3"></path></svg>
        <span class="text-gray-600">Reduced risk of treatment-related discontinuations</span>
      </li>
      <li class="flex items-start mb-2">
        <svg class="w-4 h-4 text-green-600 mr-2" fill="none" stroke="currentColor" viewBox="0 0 24 24" xmlns="http://www.w3.org/2000/svg"><path stroke-linecap="round" stroke-linejoin="round" stroke-width="2" d="M9 12l2 2 4-4m5-3l2 2 4-4M12 9v3"></path></svg>
        <span class="text-gray-600">Improved patient quality of life during treatment</span>
      </li>
    </ul>
    <p class="text-gray-600 mb-4">Oncozen's safety profile is supported by robust clinical trial data, demonstrating a significant reduction in severe adverse events and treatment-related discontinuations compared to existing treatments.</p>
  </div>
</html>